首页> 外文OA文献 >Real-World Evidence of Improved Patient Outcomes with Reslizumab in Adults with Severe Eosinophilic Asthma: A Subgroup Analysis of Patients Receiving Reslizumab for More Than 12 Months

【2h】

Real-World Evidence of Improved Patient Outcomes with Reslizumab in Adults with Severe Eosinophilic Asthma: A Subgroup Analysis of Patients Receiving Reslizumab for More Than 12 Months

机译：具有严重嗜酸性哮喘的成年人的患者结果改善患者结果的现实迹象：患者患者患者超过12个月的亚组分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
M. Wechsler; S.P. Peters; B.E. Chipps; T. Hill; R. Ariely; M. DePietro; M. Driessen; E. Terasawa; D. Thomason; R.A. Panettieri;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. REAL-WORLD EVIDENCE OF IMPROVED PATIENT OUTCOMES WITH RESLIZUMAB IN ADULTS WITH SEVERE EOSINOPHILIC ASTHMA (SEA) [J] . Wechsler M., Peters S., Chipps B., Annals of allergy, asthma, and immunology . 2019,第5Suppla1期

机译：具有严重嗜酸性嗜嗜酸性哮喘（海）的成年人中缺血剂改善患者结果的现实世界证据
2. RESLIZUMAB IMPROVES SPIROMETRIC LUNG AGE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA [J] . Carr W., McDonald M., Meizlik P. Annals of allergy, asthma, and immunology . 2017,第5Suppla1期

机译：Reslizumab改善了严重嗜酸性哮喘患者的肺活动力
3. RESLIZUMAB IMPROVES SPIROMETRIC LUNG AGE IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA [J] . Carr W., McDonald M., Meizlik P. Annals of allergy, asthma, and immunology . 2017,第5Suppla1期

机译：Reslizumab改善了严重嗜酸性哮喘患者的肺活动力
4. A Mobile Video Information Provider (VIP) for Dissemination of Evidence from Patient-Centered Outcomes Research for Improving Symptom Management [C] . Rebecca SCHNALL, Hwayoung CHO, Adrienne PICHON, European Federation for Medical Informatics., Special Topic Conference. . 2017

机译：移动视频信息提供商（VIP），用于传播来自患者以患者为中心的结果的证据改善症状管理
5. Nursing sensitive process and outcome measures in patients with adult respiratory distress syndrome (ARDS) receiving mechanical ventilation. [D] . Jones, Terry Lynn. 2004

机译：成人接受机械通气的呼吸窘迫综合征（ARDS）患者的护理敏感过程和结局指标。
6. Mepolizumab improves sino-nasal symptoms and asthma control in severe eosinophilic asthma patients with chronic rhinosinusitis and nasal polyps: a 12-month real-life study [O] . Aikaterini Detoraki, Eugenio Tremante, Maria D’Amato, 2021

机译：Mepolizumab在严重嗜酸性哮喘患者慢性鼻窦炎和鼻息肉中改善中鼻症状和哮喘控制：一个12个月的真实研究
7. PRS54 - COST-EFFECTIVENESS ANALYSIS OF RESLIZUMAB FOR PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA INADEQUATELY CONTROLLED WITH HIGH-DOSE INHALED CORTICOSTEROIDS AND LONG-ACTING B2-AGONISTS IN SOUTH KOREA [O] . S. Han, S. Kim, H. Kim, 2018

机译：PRS54 - 具有高剂量吸入皮质类固醇和韩国的长效B2激动剂的严重嗜酸性哮喘患者的患者的成本效益分析

Real-World Evidence of Improved Patient Outcomes with Reslizumab in Adults with Severe Eosinophilic Asthma: A Subgroup Analysis of Patients Receiving Reslizumab for More Than 12 Months

著录项

引文网络

相似文献

相关主题

期刊订阅